Atopic Dermatitis
📧 Sign up to get email alerts when something new happens for Atopic Dermatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-12-17Clinical Trial Update: Topical Ruxolitinib Evaluation in Atopic Dermatitis Study 1 (TRuE AD1) - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis [Phase 3]
Phase 3 clinical trial evaluating topical ruxolitinib cream for atopic dermatitis in adolescents and adults has completed with results poste…
-
CLINICAL_TRIALS trial_result · 2021-11-29Clinical Trial Update: Evaluating the Efficacy and Tolerability of Ceradan Advanced Cream in the Treatment of Children With Atopic Dermatitis [Phase 3]
Phase 3 trial evaluating efficacy and tolerability of Ceradan Advanced Cream in children with atopic dermatitis; status currently unknown.
-
CLINICAL_TRIALS trial_result · 2021-11-23Clinical Trial Update: A Study to Evaluate the Effectiveness and Safety of Topical OPA-15406 Ointment to Treat Participants With Atopic Dermatitis [Phase 2]
Phase 2 trial evaluating the effectiveness and safety of topical OPA-15406 ointment for atopic dermatitis has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-11-22Clinical Trial Update: A Phase 2 Study of CIM331 for Atopic Dermatitis Patients [Phase 2]
Phase 2 trial of CIM331 for atopic dermatitis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-11-19Clinical Trial Update: Long-term Trial of OPA-15406 Ointment in Adult and Pediatric Patients With Atopic Dermatitis [Phase 3]
Phase 3 long-term trial of OPA-15406 ointment in adults and children with atopic dermatitis completed; results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-11-18Clinical Trial Update: A Study to Evaluate Risankizumab in Adults and Adolescents With Moderate to Severe Atopic Dermatitis [Phase 2]
Phase 2 study evaluating risankizumab in adults and adolescents with moderate to severe atopic dermatitis completed; results posted.
-
FDA approval · 2021-11-04FDA Approved: HYDROCORTISONE VALERATE CREAM — Original Application (Encube Ethicals, Inc.)
FDA approved Hydrocortisone Valerate Cream by Encube Ethicals as an Original Application; a generic topical corticosteroid indicated for inf…
-
CLINICAL_TRIALS trial_result · 2021-11-01Clinical Trial Update: Efficacy and Safety of REGN3500 Monotherapy and Combination of REGN3500 Plus Dupilumab in Adult Patients With Moderate-to-Severe Atopic Dermatitis [Phase 2]
Phase 2 trial evaluating REGN3500 alone and with dupilumab in adults with moderate-to-severe atopic dermatitis terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2021-10-29Clinical Trial Update: Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6). [Phase 3]
Phase 3 ECZTRA 6 evaluated tralokinumab monotherapy in adolescents with moderate to severe atopic dermatitis; the trial completed and result…
-
CLINICAL_TRIALS trial_result · 2021-10-26Clinical Trial Update: Tralokinumab in Combination With Topical Corticosteroids in Subjects With Severe Atopic Dermatitis - ECZTRA 7 [Phase 3]
ECZTRA 7, a Phase 3 trial evaluating tralokinumab in combination with topical corticosteroids for severe atopic dermatitis, has completed wi…
-
CLINICAL_TRIALS trial_result · 2021-10-08Clinical Trial Update: An Investigator-initiated Study of Apremilast to Demonstrate Efficacy Nummular Eczema [Phase 2]
Phase 2 investigator-initiated trial evaluating apremilast for efficacy in Nummular Eczema (dermatitis) has completed.
-
CLINICAL_TRIALS trial_result · 2021-10-05Clinical Trial Update: Topical Application of BMX-010 in Subjects With Atopic Dermatitis and Plaque Psoriasis [Phase 2]
Phase 2 clinical trial update for topical BMX-010 in subjects with psoriasis and atopic dermatitis has completed.
-
FDA approval · 2021-09-21FDA Approved: OPZELURA — Original Application (Incyte Corporation)
FDA approved OPZELURA (ruxolitinib) cream as the original approval for the topical treatment of atopic dermatitis.
-
CLINICAL_TRIALS trial_result · 2021-09-20Clinical Trial Update: Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects [Phase 3]
Phase 3 trial evaluating PF-04965842 for moderate to severe atopic dermatitis (eczema) in patients aged 12 and older; completed with results…
-
CLINICAL_TRIALS trial_result · 2021-09-16Clinical Trial Update: Thykamine Safety and Efficacy Study in Mild-to-Moderate Atopic Dermatitis [Phase 2]
Phase 2 trial update reporting safety and efficacy results for Thykamine in mild-to-moderate atopic dermatitis (eczema).
-
CLINICAL_TRIALS trial_result · 2021-09-16Clinical Trial Update: Evaluation of FB-401 in Children, Adolescents and Adults (2 Years and Older) With Mild to Moderate Atopic Dermatitis [Phase 2]
Phase 2 clinical trial evaluating FB-401 in children, adolescents, and adults (2 years and older) with mild to moderate atopic dermatitis ha…
-
CLINICAL_TRIALS trial_result · 2021-08-24Clinical Trial Update: Different Application Rates of Crisaborole Ointment 2% in Adults With Mild to Moderate Atopic Dermatitis [Phase 4]
Phase 4 trial investigating different application rates of crisaborole 2% ointment in adults with mild to moderate atopic dermatitis has com…
-
CLINICAL_TRIALS trial_result · 2021-08-13Clinical Trial Update: Safety and Efficacy of FURESTEM-AD Inj. for Moderate to Severe Atopic Dermatitis (AD) [Phase 3]
Phase 3 trial update on FURESTEM-AD Injection for moderate to severe atopic dermatitis, with safety and efficacy data yet to be determined.
-
CLINICAL_TRIALS trial_result · 2021-08-12Clinical Trial Update: A Study of the Long-Term Safety of Crisaborole Ointment, 2% in Japanese Pediatric and Adult Participants With Mild to Moderate Atopic Dermatitis [Phase 3]
A Phase 3 long-term safety trial of Crisaborole ointment 2% in Japanese participants with mild to moderate atopic dermatitis was terminated …
-
CLINICAL_TRIALS trial_result · 2021-07-20Clinical Trial Update: A Safety and Efficacy of DRM02 in Subjects With Atopic Dermatitis [Phase 2]
Phase 2 clinical trial update assessing safety and efficacy of DRM02 in subjects with atopic dermatitis.
-
CLINICAL_TRIALS trial_result · 2021-07-20Clinical Trial Update: A Study to Assess the Safety and Efficacy of ZPL389 With TCS/TCI in Atopic Dermatitis Patients [Phase 2]
Phase 2 trial assessing safety and efficacy of ZPL389 with TCS/TCI in atopic dermatitis; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2021-07-20Clinical Trial Update: A Study to Assess the Safety and Efficacy of ZPL389 in Patients With Moderate to Severe Atopic Dermatitis [Phase 2]
Phase 2 trial of ZPL389 in moderate to severe atopic dermatitis was terminated; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-07-13Clinical Trial Update: Immunologic Basis of Anti-IgE Therapy (Study II: On Patients With Asthma) [Phase 4]
Phase 4 clinical trial update on the immunologic basis of anti-IgE therapy in patients with asthma and related allergic conditions.
-
CLINICAL_TRIALS trial_result · 2021-07-08Clinical Trial Update: Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over an 8-week Treatment Period in Adult Subjects With Atopic Dermatitis. [Phase 2]
Phase 2 dose-ranging trial evaluating delgocitinib cream at 1, 3, 8, and 20 mg/g versus vehicle over 8 weeks in adults with atopic dermatiti…
-
CLINICAL_TRIALS trial_result · 2021-06-23Clinical Trial Update: Clobetasol Topical Oil for Children With Moderate to Severe Atopic Dermatitis [Phase 1, Phase 2]
A Phase 1/2 clinical trial of clobetasol topical oil for children with moderate to severe atopic dermatitis was terminated; results have bee…